Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GNVC

Genvec, Inc. (GNVC)

Genvec, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GNVC
DateHeureSourceTitreSymboleSociété
26/06/201722h17Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:GNVCGenvec, Inc.
20/06/201722h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNVCGenvec, Inc.
16/06/201717h08Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNVCGenvec, Inc.
16/06/201716h34Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNVCGenvec, Inc.
16/06/201716h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNVCGenvec, Inc.
16/06/201715h15PR Newswire (US)Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec AcquisitionNASDAQ:GNVCGenvec, Inc.
16/06/201715h09Edgar (US Regulatory)(25-NSE)NASDAQ:GNVCGenvec, Inc.
12/05/201722h37Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:GNVCGenvec, Inc.
10/05/201722h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNVCGenvec, Inc.
24/04/201701h35PR Newswire (US)Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVCNASDAQ:GNVCGenvec, Inc.
14/03/201722h29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNVCGenvec, Inc.
14/03/201721h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNVCGenvec, Inc.
06/03/201722h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNVCGenvec, Inc.
01/03/201723h10PR Newswire (US)Intrexon Announces Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
16/02/201722h37Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GNVCGenvec, Inc.
09/02/201700h56PR Newswire (US)WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC ShareholdersNASDAQ:GNVCGenvec, Inc.
24/01/201722h57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNVCGenvec, Inc.
24/01/201722h07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GNVCGenvec, Inc.
24/01/201715h00PR Newswire (US)Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery PlatformNASDAQ:GNVCGenvec, Inc.
11/01/201714h00PR Newswire (US)GenVec to Present at Phacilitate Cell & Gene Therapy World 2017NASDAQ:GNVCGenvec, Inc.
01/12/201613h00PR Newswire (US)GenVec Effects 1-for-10 Reverse Stock SplitNASDAQ:GNVCGenvec, Inc.
04/11/201612h30PR Newswire (US)GenVec Reports Third Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
28/09/201614h00PR Newswire (US)GenVec To Present At 2016 Cell & Gene Meeting On The MesaNASDAQ:GNVCGenvec, Inc.
12/09/201618h22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNVCGenvec, Inc.
02/09/201622h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GNVCGenvec, Inc.
26/08/201622h16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNVCGenvec, Inc.
05/08/201613h30PR Newswire (US)GenVec Reports Second Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
25/07/201613h30PR Newswire (US)FDA Lifts Clinical Hold On CGF166NASDAQ:GNVCGenvec, Inc.
12/05/201614h00PR Newswire (US)GenVec Reports First Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
06/05/201623h57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GNVCGenvec, Inc.
 Showing the most relevant articles for your search:NASDAQ:GNVC